Fatty acids and Alzheimer’s Disease: Evidence on Cognition and Cortical β-amyloid from Secondary Analyses of the Multidomain Alzheimer Preventive Trial

  • Claudie HooperEmail author
  • B. Vellas
  • MAPT/DSA study group


  1. 1.
    White B. Dietary fatty acids. Am Fam Physician. 2009. 80(4):345–50.PubMedGoogle Scholar
  2. 2.
    Thomas MH, Pelleieux S, Vitale N, Olivier JL. Dietary arachidonic acid as a risk factor for age-associated neurodegenerative diseases: Potential mechanisms. Biochimie. 2016. 26.Google Scholar
  3. 3.
    Carlson SE, Colombo J. Docosahexaenoic Acid and Arachidonic Acid Nutrition in Early Development. Adv Pediatr. 2016. 63(1):453–71.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Hooper C., De Souto Barreto P., Pahor M., Weiner M., Vellas B. The relationship of omega 3 polyunsaturated fatty acids in red blood cell membranes with cognitive function and brain structure: A review focussed on Alzheimer’s disease. Journal of prevention of Alzheimer’s disease. J Prev Alzheimers Dis. 2017. 19.Google Scholar
  5. 5.
    Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014. 15(12):771–85.CrossRefPubMedGoogle Scholar
  6. 6.
    Vellas B, Carrie I, Gillette-Guyonnet S, Touchon J, Dantoine T, Dartigues JF, et al. MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA. J Prev Alzheimers Dis. 2014. 1(1):13–22.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017. 16(5):377–389.CrossRefPubMedGoogle Scholar
  8. 8.
    Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, et al. Relationship of regional brain β-amyloid to gait speed. Neurology. 2016. 86(1):36–43.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer’s disease and cognitively normal subjects. J Nucl Med Off Publ Soc Nucl Med. 2012. 53(3):378–84.Google Scholar
  10. 10.
    J.K Chhetri, P. de Souto Barreto, C. Cantet, M. Cesari, N. Coley, S. Andrieu, B. Vellas. Trajectory of the MAPT-PACC Preclinical Alzheimer Cognitive Composite in the placebo group of a randomized control trial: Results from the MAPT study: Lessons for further trials. J Prev Alzheimers Dis. 2017. (in press).Google Scholar
  11. 11.
    Hooper C., De Souto Barreto P., Coley N., Cantet C., Cesari M., Andrieu S., Vellas B. Cognitive changes with omega-3 polyunsaturated fatty acids in nondemented older adults with low omega-3 index. J Nutr Health Aging. 2017. 21, 988–993.CrossRefPubMedGoogle Scholar
  12. 12.
    Kivipelto M, Mangialasche F, Ngandu T. Can lifestyle changes prevent cognitive impairment? Lancet Neurol. 2017. 16(5):338–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Hooper C, De Souto Barreto P, Payoux P, Salabert AS, Guyonnet S, Andrieu S, et al. Cross-sectional associations of cortical β-amyloid with erythrocyte membrane long-chain polyunsaturated fatty acids in older adults with subjective memory complaints. J Neurochem. 2017. 142, 589–596.CrossRefPubMedGoogle Scholar
  14. 14.
    Hooper C., De Souto Barreto P., Payoux P., Salabert A. S., Guyonnet S., Andrieu S., Vellas B. Association of cortical B-amyloid with erythrocyte membrane monounsaturated and saturated fatty acids in older adults at risk of dementia. J Nutr Health Aging. 2017. 21(10):1170–1175.CrossRefPubMedGoogle Scholar
  15. 15.
    Yang X, Sheng W, Sun GY, Lee JC-M. Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase-dependent amyloid precursor protein processing. Neurochem Int. 2011. 58(3):321–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Heude B, Ducimetière P, Berr C, EVA Study. Cognitive decline and fatty acid composition of erythrocyte membranes—The EVA Study. Am J Clin Nutr. 2003. 77(4):803–8.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Claudie Hooper
    • 1
    Email author
  • B. Vellas
    • 1
    • 2
  • MAPT/DSA study group
  1. 1.Gérontopôle, Department of GeriatricsCHU Toulouse, Purpan University HospitalToulouseFrance
  2. 2.MR1027Université de Toulouse, UPS, INSERMToulouseFrance

Personalised recommendations